Viz.ai Stock
HealthTechLooking to sell Viz.ai stock or options?
Contact usFounded: 2016Funding to Date: $293M
Visit websiteViz.ai, a developer of a smart care coordination platform, is dedicated to revolutionizing global healthcare delivery. The company's platform harnesses the power of advanced deep learning to relay critical information about stroke patients directly to a specialist who can provide immediate treatment. This enables healthcare providers to decrease treatment times and enhance patient access to care.
Investors include:
Further Key Investors:
Susa Ventures, Greenoaks Capital Partners, AME Cloud Ventures, Seedcamp, Kevin Ding, Threshold Ventures, Jukka Jokinen, Halle Tecco, Collective Liquidity, Scale Venture Partners, GV, CRV, DHVC, Geodesic Capital, Pear, J Mocco, Canadian Imperial Bank of Commerce, Hakluyt Capital, Innovation Endeavors, Sozo Ventures.
Looking to sell Viz.ai Stock or Options?
We have an even better solution: The Collective Exchange Fund
Get in touch and see if we can help you
Loading
Management Team
Gad SakinChief Product Officer and General Manager
Manoj RamachandranCo-Founder
Chris MansiCo-Founder, Chief Executive Officer & Board Member
Lisa GarlandVice President of Finance
Kurt BlasenaChief Revenue Officer
Kelli CastellanoChief Marketing Officer
David GolanCo-Founder, Chief Technology Officer & Board Member
Julie SkaffChief Operating Officer
Jayme StraussChief Clinical Officer
Steve FriedVice President, Sales
Board Members
Neil ShahBoard Member
Rory T. O'DriscollBoard Member
Mamoon HamidBoard Member
David GolanBoard Member
Chris MansiBoard Member
Kevin Ruoyu DingBoard Member
Other HealthTech companies from Collective's Target Portfolio
Companies backed by the same VC's
Viz.ai in the News
Source: 01netViz.ai and Medtronic Collaborate to Improve Post-Acute Stroke Patient Care in the United States
Collaboration aims to help cryptogenic stroke patients receive necessary cardiology follow-up to reduce risk of secondary strokeSAN FRANCISCO--(BUSINESS
Source: 01netViz.ai Receives FDA 510(k) Clearance for Artificial Intelligence Algorithm for the Quantification of Intracerebral Hemorrhage
New AI algorithm enables precise and reliable quantification of intracerebral hemorrhage to make accurate and timely treatment decisionsSAN
Source: Medical Device NetworkViz.ai’s aneurysm diagnostic tool is 97.2% predictive in ruling out stroke
The AI-powered diagnostic platform can diagnose the presence of aneurysms by analysing computed tomography (CT) scans.
Source: ForbesHow Viz.ai Uses Artificial Intelligence To Treat Stroke Patients Faster
The startup has 12 FDA-approved algorithms, agreements with more than 1,500 U.S. hospitals, and plans to work with drug companies to reduce healthcare roadblocks.
Source: Business WireViz.ai Launches AI-Powered Viz™ Vascular Suite
SAN FRANCISCO--(BUSINESS WIRE)-- #ai--Viz.ai, the leader in AI-powered disease detection and intelligent care coordination, today announced the launch of VizTM Vascular Suite, AI-powered software enabling vascular care teams to automatically detect and triage…
Source: Business WireViz.ai Wins Four Comparably Awards for Best Place to Work
SAN FRANCISCO--(BUSINESS WIRE)-- #ai--Viz.ai, the leader in AI-powered disease detection and intelligent care coordination, has received two additional Comparably Best Place to Work Awards for Best Company Culture and Best Company for Diversity in 2022. Earli…
Source: Business WireViz.ai and Cercare Medical Partner to Support Neurovascular Clinical DecisionMaking
SAN FRANCISCO--(BUSINESS WIRE)-- #ai--Viz.ai, the leader in AI-powered disease detection and intelligent care coordination, today announced a partnership with Cercare Medical, which delivers next-level medical imaging with CT and MRI. The partnership will inc…
Source: Business WireViz.ai Appoints Radiology Advisory Board to Advance Innovation
SAN FRANCISCO--(BUSINESS WIRE)-- #ai--Viz.ai, the leader in AI-powered disease detection and intelligent care coordination, today announced the creation of its Radiology Advisory Board to assist Viz.ai in the development of strategy and products to support ra…
Source: Business WireViz.ai and Vastrax Join Forces to Accelerate Clinical Trial Enrollment
SAN FRANCISCO--(BUSINESS WIRE)-- #AI--Viz.ai, the leader in AI-powered disease detection and intelligent care coordination, today announced a strategic partnership with Vastrax, the leading full-service, vascular clinical research organization (CRO). Together…
Source: Business WireViz.ai Launches AI-Powered VizTM Cardio Suite
CHICAGO & SAN FRANCISCO--(BUSINESS WIRE)-- #AHA2022--AMERICAN HEART ASSOCIATION SCIENTIFIC SESSIONS-- Viz.ai, the leader in AI-powered disease detection and intelligent care coordination, today announced the launch of a full cardiology suite to speed and impr…